127 related articles for article (PubMed ID: 37725590)
1. Fracture Incidence in Graves' Disease: A Population-Based Study.
Khamisi S; Udumyan R; Sjölin G; Calissendorff J; Filipsson Nyström H; Holmberg M; Hallengren B; Lantz M; Planck T; Wallin G; Ljunggren Ö
Thyroid; 2023 Nov; 33(11):1349-1357. PubMed ID: 37725590
[No Abstract] [Full Text] [Related]
2. Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study.
Hasserius R; Karlsson MK; Nilsson BE; Redlund-Johnell I; Johnell O;
Osteoporos Int; 2003 Jan; 14(1):61-8. PubMed ID: 12577186
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease and vertebral fracture: Possible pathogenic link in postmenopausal women.
Takedani K; Notsu M; Yamauchi M; Nawata K; Sugimoto T; Kanasaki K
Clin Endocrinol (Oxf); 2020 Aug; 93(2):204-211. PubMed ID: 32324288
[TBL] [Abstract][Full Text] [Related]
4. Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study.
Cho YY; Kim B; Shin DW; Jang HR; Kim BY; Jung CH; Kim JH; Kim SW; Chung JH; Han K; Kim TH
Endocrinol Metab (Seoul); 2022 Apr; 37(2):281-289. PubMed ID: 35381687
[TBL] [Abstract][Full Text] [Related]
5. Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study.
Ohlsson C; Mellström D; Carlzon D; Orwoll E; Ljunggren O; Karlsson MK; Vandenput L
J Bone Miner Res; 2011 Apr; 26(4):865-72. PubMed ID: 21433071
[TBL] [Abstract][Full Text] [Related]
6. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
7. The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women.
Morin SN; Lix LM; Leslie WD
J Bone Miner Res; 2014 Jul; 29(7):1675-80. PubMed ID: 24535832
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in patients with Graves' disease: a nationwide cohort study.
Chen YK; Lin CL; Chang YJ; Cheng FT; Peng CL; Sung FC; Cheng YH; Kao CH
Thyroid; 2013 Jul; 23(7):879-84. PubMed ID: 23421548
[TBL] [Abstract][Full Text] [Related]
9. The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study.
Yoshihara A; Yoshimura Noh J; Mukasa K; Watanabe N; Iwaku K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Endo K; Suzuki R; Hattori N; Sugino K; Ito K
Endocr J; 2016 Dec; 63(12):1113-1122. PubMed ID: 27600197
[TBL] [Abstract][Full Text] [Related]
10. Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.
Folkestad L; Brandt F; Lillevang-Johansen M; Brix TH; Hegedüs L
Thyroid; 2020 May; 30(5):672-680. PubMed ID: 31984866
[No Abstract] [Full Text] [Related]
11. Graves' Disease in Children Presenting With Fragility Fracture: A Case Report.
Yuan C; Lyu J; Liu Y; Sun X; Wu J
Altern Ther Health Med; 2023 Apr; 29(3):262-265. PubMed ID: 36634316
[TBL] [Abstract][Full Text] [Related]
12. Low Serum DHEAS Predicts Increased Fracture Risk in Older Men: The MrOS Sweden Study.
Ohlsson C; Nethander M; Kindmark A; Ljunggren Ö; Lorentzon M; Rosengren BE; Karlsson MK; Mellström D; Vandenput L
J Bone Miner Res; 2017 Aug; 32(8):1607-1614. PubMed ID: 28276592
[TBL] [Abstract][Full Text] [Related]
13. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
[TBL] [Abstract][Full Text] [Related]
14. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.
Bliuc D; Nguyen ND; Milch VE; Nguyen TV; Eisman JA; Center JR
JAMA; 2009 Feb; 301(5):513-21. PubMed ID: 19190316
[TBL] [Abstract][Full Text] [Related]
15. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
Samelson EJ; Broe KE; Xu H; Yang L; Boyd S; Biver E; Szulc P; Adachi J; Amin S; Atkinson E; Berger C; Burt L; Chapurlat R; Chevalley T; Ferrari S; Goltzman D; Hanley DA; Hannan MT; Khosla S; Liu CT; Lorentzon M; Mellstrom D; Merle B; Nethander M; Rizzoli R; Sornay-Rendu E; Van Rietbergen B; Sundh D; Wong AKO; Ohlsson C; Demissie S; Kiel DP; Bouxsein ML
Lancet Diabetes Endocrinol; 2019 Jan; 7(1):34-43. PubMed ID: 30503163
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and predictors of fractures associated with osteoporosis.
Lips P
Am J Med; 1997 Aug; 103(2A):3S-8S; discussion 8S-11S. PubMed ID: 9302892
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism.
Le Moli R; Malandrino P; Russo M; Lo Giudice F; Frasca F; Belfiore A; Vigneri R
Front Endocrinol (Lausanne); 2020; 11():367. PubMed ID: 32595602
[No Abstract] [Full Text] [Related]
18. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study.
Yao S; Laurent CA; Roh JM; Lo J; Tang L; Hahn T; Ambrosone CB; Kushi LH; Kwan ML
Breast Cancer Res Treat; 2020 Feb; 180(1):187-195. PubMed ID: 31912328
[TBL] [Abstract][Full Text] [Related]
19. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
20. Hyperthyroid patients without Graves' orbitopathy are not at increased risk of developing glaucoma: a nationwide Danish register-based case-control study.
Brandt F; Thvilum M; Hegedüs L; Brix TH
Endocrine; 2018 Jan; 59(1):137-142. PubMed ID: 29198022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
